An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues

被引:144
作者
Chakraverty, Ronjon
Cote, Daniel
Buchli, Jennifer
Cotter, Pete
Hsu, Richard
Zhao, Guiling
Sachs, Teviah
Pitsillides, Costas M.
Bronson, Roderick
Means, Terry
Lin, Charles
Sykes, Megan [1 ]
机构
[1] Massachusetts Gen Hosp, Transplantat Biol Res Ctr, Bone Marrow Transplantat Sect, Boston, MA 02129 USA
[2] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02129 USA
[3] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02129 USA
[4] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02129 USA
关键词
D O I
10.1084/jem.20060376
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Transfer of T cells to freshly irradiated allogeneic recipients leads to their rapid recruitment to nonlymphoid tissues, where they induce graft-versus-host disease (GVHD). In contrast, when donor T cells are transferred to established mixed chimeras (MCs), GVHD is not induced despite a robust graft-versus-host (GVH) reaction that eliminates normal and malignant host hematopoietic cells. We demonstrate here that donor GVH-reactive T cells transferred to MCs or freshly irradiated mice undergo similar expansion and activation, with similar up-regulation of homing molecules required for entry to nonlymphoid tissues. Using dynamic two-photon in vivo microscopy, we show that these activated T cells do not enter GVHD target tissues in established MCs, contrary to the dogma that activated T cells inevitably traffic to nonlymphoid tissues. Instead, we show that the presence of inflammation within a nonlymphoid tissue is a prerequisite for the trafficking of activated T cells to that site. Our studies help to explain the paradox whereby GVH-reactive T cells can mediate graft-versus-leukemia responses without inducing GVHD in established MCs.
引用
收藏
页码:2021 / 2031
页数:11
相关论文
共 59 条
[1]   Chemokines in islet allograft rejection [J].
Abdi, R ;
Means, TK ;
Luster, AD .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2003, 19 (03) :186-190
[2]   In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets [J].
Beilhack, A ;
Schulz, S ;
Baker, J ;
Beilhack, GF ;
Wieland, CB ;
Herman, EI ;
Baker, EM ;
Cao, YA ;
Contag, CH ;
Negrin, RS .
BLOOD, 2005, 106 (03) :1113-1122
[3]  
BRISCOE DM, 1992, J IMMUNOL, V149, P2954
[4]   Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide [J].
Caramalho, I ;
Lopes-Carvalho, T ;
Ostler, D ;
Zelenay, S ;
Haury, M ;
Demengeot, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (04) :403-411
[5]   Direct stimulation of human T cells via TLR5 and TLR7/8:: Flagellin and R-848 up-regulate proliferation and IFN-γ production by memory CD4+ T cells [J].
Caron, G ;
Duluc, D ;
Frémaux, I ;
Jeannin, P ;
David, C ;
Gascan, H ;
Delneste, Y .
JOURNAL OF IMMUNOLOGY, 2005, 175 (03) :1551-1557
[6]  
CHAKRAVERTY R, IN PRESS BLOOD
[7]   The allograft defines the type of rejection (acute versus chronic) in the face of an established effector immune response [J].
Chalasani, G ;
Li, Q ;
Konieczny, BT ;
Smith-Diggs, L ;
Wrobel, B ;
Dai, ZH ;
Perkins, DL ;
Baddoura, FK ;
Lakkis, FG .
JOURNAL OF IMMUNOLOGY, 2004, 172 (12) :7813-7820
[8]   The third signal in T cell-mediated autoimmune disease? [J].
Darabi, K ;
Karulin, AY ;
Boehm, BO ;
Hofstetter, HH ;
Fabry, Z ;
LaManna, JC ;
Chavez, JC ;
Tary-Lehmann, M ;
Lehmann, PV .
JOURNAL OF IMMUNOLOGY, 2004, 173 (01) :92-99
[9]   The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model [J].
Dey, B ;
Yang, YG ;
Preffer, F ;
Shimizu, A ;
Swenson, K ;
Dombkowski, D ;
Sykes, M .
TRANSPLANTATION, 1999, 68 (01) :141-149
[10]   Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriers [J].
Eyrich, M ;
Burger, G ;
Marquardt, K ;
Budach, W ;
Schilbach, K ;
Niethammer, D ;
Schlegel, PG .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (05) :371-382